Detalhe da pesquisa
1.
Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis.
Hepatology
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452004
2.
Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study.
Clin Infect Dis
; 76(3): e652-e660, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35903910
3.
Human IgMhiCD300a+ B Cells Are Circulating Marginal Zone Memory B Cells That Respond to Pneumococcal Polysaccharides and Their Frequency Is Decreased in People Living with HIV.
Int J Mol Sci
; 24(18)2023 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762055
4.
Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals.
Gastroenterol Hepatol
; 45(4): 249-255, 2022 Apr.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-34562521
5.
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study.
HIV Med
; 22(9): 867-876, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324783
6.
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort.
Clin Microbiol Infect
; 27(11): 1678-1684, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34186209
7.
Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals / Evolución de la porfiria cutánea tarda asociada al VHC tras obtenerse respuesta virológica sostenida del VHC mediante el uso de antivirales de acción directa
Gastroenterol. hepatol. (Ed. impr.)
; 45(4): 249-255, Abr. 2022. tab, graf
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-204218